Erectile dysfunction.
By A. L. A S T A I, R. J. J. W. O O D, E. Rectile, D. Ysfunction, T. Om, F. L. Ue, Penile Flaccidity. Harvard men's health watch, 2006
2,674 citations recorded by the source corpus.
View Paper: https://www.semanticscholar.org/paper/de3282910eef0c808b4d49f4ce3707d82be662a8
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- Michael Kuhn
- Ivica Letunic
- Peer Bork
- Lars Juhl Jensen
- Damian Szklarczyk
- Monica Campillos
- A. Boulton
- V. Spallone
Citations in the corpus
- A side effect resource to capture phenotypic effects of drugs (2010, background): “The occurrence of erectile dysfunction for non-selective b -blockers has been explained with their action on a - adrenergic receptors in penile tissue (Lue, 2000), thus providing an example of closely related off-targets in different tissues.”
- Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation. (2010, unknown): “Inhibition of PDE5 results in increased arterial blood flow leading to smooth muscle relaxation, vasodilatation and penile erection (30).”
- Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity, and Treatments (2010, background): “Neuropathy is one of the leading causes of ED, along with glycation of elastic fibers, peripheral vasculopathy, endothelial dysfunction, psychological factors, drugs, and hormonal changes (47).”
- European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (Version 2012) (2012, unknown): “It may result from psychological, neurological, hormonal, arterial, or cavernosal impairment or from a combination of these factors.(179,181) ED has a high prevalence in individuals with multiple cardiovascular risk factors and in individuals with CVD.”